These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3020609)

  • 1. Breast tumors: evaluation with P-31 MR spectroscopy.
    Degani H; Horowitz A; Itzchak Y
    Radiology; 1986 Oct; 161(1):53-5. PubMed ID: 3020609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.
    Sijens PE; Wijrdeman HK; Moerland MA; Bakker CJ; Vermeulen JW; Luyten PR
    Radiology; 1988 Dec; 169(3):615-20. PubMed ID: 2847230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the human female breast. Current status and pathologic correlations.
    Powell DE; Stelling CB
    Pathol Annu; 1988; 23 Pt 1():159-94. PubMed ID: 2838793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
    Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
    AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the human breast: a Phase I trial.
    El Yousef SJ; Duchesneau RH
    Radiol Clin North Am; 1984 Dec; 22(4):859-68. PubMed ID: 6096921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging in the diagnosis of breast disease: use of transverse relaxation times.
    McSweeney MB; Small WC; Cerny V; Sewell W; Powell RW; Goldstein JH
    Radiology; 1984 Dec; 153(3):741-4. PubMed ID: 6093191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
    Yeung DK; Yang WT; Tse GM
    Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. A Nuclear Magnetic Resonance study.
    Barzilai A; Horowitz A; Geier A; Degani H
    Cancer; 1991 Jun; 67(11):2919-25. PubMed ID: 1851051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance of the breast. Clinical experience with a dedicated coil].
    Beomonte Zobel B; Testa A; Tella S; Masciocchi C; Gallucci M; Ciccozzi A; Ventura T; Passariello R
    Radiol Med; 1988 Sep; 76(3):146-51. PubMed ID: 2845488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregnancy protein-1 in the serum of patients with diseases of the breast].
    Strache RR; Briese V; Szabo DG; Than GN; Kunze M; Richter D
    Zentralbl Gynakol; 1987; 109(5):274-9. PubMed ID: 3035827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of serum CA-15.3 in the management of benign breast lesion.
    Mondal HP; Roy H; Mondal P; Saha M; Basu N
    J Indian Med Assoc; 2012 Apr; 110(4):242-4. PubMed ID: 23025224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
    Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
    Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thermobiologic evaluation of benign and malignant breast diseases].
    Gautherie M; Haehnel P; Walter JP
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):22-8. PubMed ID: 2984083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.
    Segebarth CM; Balériaux DF; Arnold DL; Luyten PR; den Hollander JA
    Radiology; 1987 Oct; 165(1):215-9. PubMed ID: 3628774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated water-path full-breast sonography: correlation with histology of 176 solid lesions.
    Egan RL; Egan KL
    AJR Am J Roentgenol; 1984 Sep; 143(3):499-507. PubMed ID: 6087645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the breast.
    el Yousef SJ; O'Connell DM
    Magn Reson Annu; 1986; ():177-95. PubMed ID: 2856325
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnetic resonance imaging in the diagnosis of breast disease.
    Dash N; Lupetin AR; Daffner RH; Deeb ZL; Sefczek RJ; Schapiro RL
    AJR Am J Roentgenol; 1986 Jan; 146(1):119-25. PubMed ID: 3484399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear magnetic resonance tomography of the breast: diagnosis, differential diagnosis, problems and possible solutions. II: Diagnosis].
    Kaiser W; Zeitler E
    Rofo; 1986 May; 144(5):572-9. PubMed ID: 3012684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative aspiration cytology of breast tumors.
    Eisenberg AJ; Hajdu SI; Wilhelmus J; Melamed MR; Kinne D
    Acta Cytol; 1986; 30(2):135-46. PubMed ID: 3008470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
    Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
    Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.